X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1408) 1408
Book Review (250) 250
Publication (55) 55
Newsletter (49) 49
Magazine Article (18) 18
Book Chapter (11) 11
Newspaper Article (11) 11
Conference Proceeding (3) 3
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1129) 1129
humans (1075) 1075
isotretinoin (973) 973
male (666) 666
female (611) 611
adult (496) 496
dermatology (388) 388
acne vulgaris - drug therapy (374) 374
acne (344) 344
isotretinoin - therapeutic use (343) 343
adolescent (286) 286
middle aged (266) 266
isotretinoin - adverse effects (248) 248
isotretinoin - administration & dosage (220) 220
antiacne agents (192) 192
animals (187) 187
13-cis-retinoic acid (178) 178
retinoids (162) 162
administration, oral (161) 161
therapy (161) 161
aged (146) 146
oncology (144) 144
treatment outcome (144) 144
retinoic acid (137) 137
care and treatment (131) 131
dermatologic agents - adverse effects (127) 127
tretinoin - therapeutic use (125) 125
dermatologic agents - therapeutic use (124) 124
isotretinoin - pharmacology (117) 117
pharmacology & pharmacy (113) 113
abridged index medicus (112) 112
young adult (107) 107
cancer (106) 106
drug therapy (104) 104
tretinoin - adverse effects (101) 101
dose-response relationship, drug (94) 94
dermatologic agents - administration & dosage (92) 92
research (92) 92
rats (89) 89
child (88) 88
pregnancy (86) 86
vitamin-a (85) 85
skin (80) 80
dermatology & venereal diseases (78) 78
acne vulgaris - blood (75) 75
medicine & public health (74) 74
risk factors (73) 73
tretinoin - administration & dosage (73) 73
health aspects (71) 71
vitamin a (71) 71
tretinoin - blood (69) 69
triglycerides - blood (69) 69
tretinoin - pharmacology (66) 66
follow-up studies (65) 65
tretinoin (64) 64
time factors (63) 63
analysis (62) 62
toxicology (62) 62
isotretinoin - blood (58) 58
pediatrics (58) 58
chemotherapy (56) 56
acne vulgaris (54) 54
metabolism (54) 54
pharmacokinetics (54) 54
differentiation (53) 53
mice (53) 53
oral isotretinoin (53) 53
expression (52) 52
acid (51) 51
administration, topical (51) 51
drug administration schedule (51) 51
drug therapy, combination (51) 51
lipids - blood (51) 51
trans-retinoic acid (51) 51
13-cis retinoic acid (50) 50
medicine, general & internal (50) 50
pharmacology/toxicology (50) 50
prevention (50) 50
child, preschool (49) 49
dosage and administration (49) 49
squamous-cell carcinoma (49) 49
vulgaris (49) 49
infant (48) 48
retinoids - therapeutic use (48) 48
keratolytic agents - therapeutic use (47) 47
prospective studies (46) 46
complications and side effects (45) 45
acute promyelocytic leukemia (44) 44
antineoplastic agents - therapeutic use (44) 44
antineoplastic combined chemotherapy protocols - therapeutic use (44) 44
etretinate (44) 44
chromatography, high pressure liquid (43) 43
diagnosis, differential (43) 43
disease (42) 42
tretinoin - analogs & derivatives (41) 41
isotretinoin - pharmacokinetics (40) 40
severity of illness index (40) 40
skin diseases - drug therapy (40) 40
acne vulgaris - pathology (39) 39
anti-bacterial agents - therapeutic use (39) 39
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1458) 1458
German (11) 11
French (8) 8
Polish (5) 5
Spanish (3) 3
Turkish (3) 3
Chinese (2) 2
Hebrew (2) 2
Korean (2) 2
Italian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American Academy of Dermatology, ISSN 0190-9622, 2017, Volume 76, Issue 6, pp. AB57 - AB57
Journal Article
Vox Sanguinis, ISSN 0042-9007, 05/2012, Volume 102, Issue 4, pp. 362 - 364
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 12/2014, Volume 171, Issue 23, pp. 5330 - 5344
Background and PurposeIsotretinoin (13-cis-retinoic acid; 13-cRA) is a differentiation inducer used to treat minimal residual disease after myeloablative... 
CELL LUNG-CANCER | RECEPTOR-ALPHA EXPRESSION | RETINOIC ACID | HUMAN NEURO-BLASTOMA | 2ND PRIMARY TUMORS | BONE-MARROW-TRANSPLANTATION | PHARMACOLOGY & PHARMACY | HIGH-RISK NEUROBLASTOMA | CANCER-STUDY-GROUP | MYELOABLATIVE THERAPY | CHILDRENS ONCOLOGY GROUP | Central Nervous System Neoplasms - blood | Microsomes - metabolism | Oncogene Proteins - genetics | Humans | Neuroblastoma - blood | Chromatography, High Pressure Liquid | RNA, Messenger - metabolism | Receptors, Retinoic Acid - genetics | Microsomes - drug effects | Tandem Mass Spectrometry | Tretinoin - analogs & derivatives | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | N-Myc Proto-Oncogene Protein | Isotretinoin - pharmacokinetics | Nuclear Proteins - genetics | Neurites - drug effects | Tretinoin - blood | Tretinoin - pharmacology | Central Nervous System Neoplasms - metabolism | Isotretinoin - pharmacology | Isotretinoin - blood | Oncogene Proteins - metabolism | Nuclear Proteins - metabolism | Receptors, Retinoic Acid - metabolism | Animals | Cytochrome P-450 CYP3A - metabolism | Neuroblastoma - drug therapy | Antineoplastic Agents - blood | Cell Line, Tumor | Cell Proliferation - drug effects | Mice, Inbred BALB C | Neuroblastoma - metabolism | Central Nervous System Neoplasms - drug therapy | Antiacne agents | Metabolites | RNA | Liver | Cytochrome P-450 | Development and progression | Isotretinoin | Neuroblastoma | Tumors | Vitamin A | Acids | Metabolism | Index Medicus | Research Papers
Journal Article
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 7/2014, Volume 74, Issue 1, pp. 177 - 183
Patients with recurrent small-cell lung cancer (SCLC) have dismal outcomes. The failure of salvage therapy is due to the possible development of resistance... 
Bcl-2 | Medicine & Public Health | Interferon alpha | Oncology | Cancer Research | 13- cis -retinoic acid | Pharmacology/Toxicology | Small-cell lung cancer | 13-cis-retinoic acid | APOPTOSIS | PROTEIN | PHASE-II | CHEMOTHERAPY | TRIAL | ETOPOSIDE | THERAPY | ONCOLOGY | PROSTATE-CANCER | RESISTANCE | PHARMACOLOGY & PHARMACY | CARCINOMA | Leukocytes, Mononuclear - metabolism | Lung Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Isotretinoin - therapeutic use | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Neoplasm Recurrence, Local - drug therapy | Isotretinoin - administration & dosage | Male | Proto-Oncogene Proteins c-bcl-2 - blood | Small Cell Lung Carcinoma - drug therapy | Small Cell Lung Carcinoma - blood | Chemotherapy-Induced Febrile Neutropenia - physiopathology | Early Termination of Clinical Trials | Leukopenia - chemically induced | Female | Paclitaxel - administration & dosage | Neoplasm Recurrence, Local - blood | Severity of Illness Index | Carcinoma, Small Cell - drug therapy | Interferon-alpha - therapeutic use | Leukopenia - physiopathology | Paclitaxel - adverse effects | Carcinoma, Small Cell - blood | Biomarkers - blood | Paclitaxel - therapeutic use | Interferon-alpha - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors | Interferon-alpha - adverse effects | Lung Neoplasms - blood | Isotretinoin - adverse effects | Cohort Studies | Relapse | Lung cancer | Analysis | Oncology, Experimental | Development and progression | Research | Biological response modifiers | Tretinoin | Cancer | Diseases | Index Medicus | small cell lung cancer | interferon alpha
Journal Article
Journal of family medicine and primary care, ISSN 2249-4863, 01/2018, Volume 7, Issue 1, pp. 171 - 174
prolonged isotretinoin therapy for various skin diseases causes change in various parameters of lipid profile. Aim: to find out the effect of low dose... 
Isotretinoin | Dosage and administration | Analysis and chemistry | Analysis | Blood | hypertriglyceridemia | isotretinoin | low dose | Hyperlipidemia | Original
Journal Article
Journal Article
Nutrition, ISSN 0899-9007, 2013, Volume 29, Issue 10, pp. 1245 - 1251
Journal Article